CN Stock MarketDetailed Quotes

301520 Anhui Wanbang Pharmaceutical Technology

Watchlist
  • 41.85
  • +1.33+3.28%
Market Closed Nov 19 15:00 CST
2.79BMarket Cap25.69P/E (TTM)

Anhui Wanbang Pharmaceutical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
21.88%293.3M
13.47%187.21M
25.14%90.17M
31.07%341.81M
33.43%240.65M
53.28%164.99M
73.61%72.06M
23.54%260.78M
180.36M
7.38%107.64M
Operating revenue
21.88%293.3M
13.47%187.21M
25.14%90.17M
31.07%341.81M
33.43%240.65M
53.28%164.99M
73.61%72.06M
23.54%260.78M
--180.36M
7.38%107.64M
Other operating revenue
----
-61.52%5.29M
----
69.20%24.65M
----
141.61%13.75M
----
36.76%14.57M
----
8.45%5.69M
Total operating cost
45.14%231.53M
35.63%141.9M
47.65%65.35M
42.30%230.81M
40.09%159.53M
46.97%104.63M
44.26M
28.79%162.2M
113.87M
23.86%71.19M
Operating cost
42.37%166.75M
26.61%100.89M
40.59%47.83M
34.89%174.53M
32.12%117.13M
46.29%79.69M
--34.02M
29.63%129.39M
--88.65M
20.45%54.47M
Operating tax surcharges
50.13%1.16M
87.11%755.01K
132.41%369.06K
52.93%1.16M
27.36%769.57K
23.29%403.5K
--158.8K
-7.72%759.01K
--604.26K
-15.44%327.27K
Operating expense
13.80%4.31M
-28.88%2.21M
-28.89%939.77K
2.12%4.54M
8.23%3.79M
37.10%3.11M
--1.32M
11.55%4.44M
--3.5M
29.39%2.27M
Administration expense
32.60%18.95M
46.23%13.03M
75.62%6.81M
65.09%20.67M
48.91%14.29M
40.40%8.91M
--3.88M
10.01%12.52M
--9.6M
13.77%6.35M
Financial expense
-689.42%-2.68M
-1,106.81%-2.14M
-3,088.43%-1.33M
-418.92%-4.61M
34.18%-339.57K
46.81%-177.51K
---41.81K
-114.51%-889.3K
---515.89K
1.02%-333.73K
-Interest expense (Financial expense)
--0
----
--0
-97.01%115.79
-96.60%115.79
-95.56%115.79
--115.79
-29.40%3.87K
--3.41K
--2.61K
-Interest Income (Financial expense)
-671.10%-2.7M
-1,059.65%-2.16M
-2,634.98%-1.34M
-411.08%-4.63M
33.68%-350.41K
45.70%-186.28K
---48.95K
-109.43%-906.05K
---528.34K
-0.39%-343.03K
Research and development
80.17%43.05M
113.95%27.15M
118.06%10.74M
116.21%34.52M
98.48%23.89M
56.51%12.69M
--4.92M
54.31%15.97M
--12.04M
66.52%8.11M
Credit Impairment Loss
-110.47%-2.41M
37.38%-920.6K
22.10%-104K
-81.57%-2.65M
-90.85%-1.15M
-274.10%-1.47M
---133.5K
-74.86%-1.46M
---600.15K
34.86%-393.01K
Asset Impairment Loss
-8.73%-1.71M
-42.33%-1.38M
-43.08%-448.9K
-72.38%-1.45M
-87.25%-1.57M
-84.77%-966.12K
---313.73K
7.45%-843.55K
---838.91K
16.84%-522.88K
Other net revenue
342.81%19.69M
10,300.71%11.78M
936.28%7.3M
6.84%8.01M
-54.28%4.45M
-94.46%113.26K
704.92K
269.34%7.5M
9.73M
187.72%2.05M
Fair value change income
2,305.71%20.65M
--11.98M
--6.88M
--3.79M
--858.25K
----
----
----
--0
----
Invest income
1.55%2.04M
-23.43%1.33M
-16.45%679.3K
-23.38%2.43M
-17.32%2.01M
10.72%1.74M
--813.02K
71.31%3.18M
--2.43M
134.91%1.57M
Asset deal income
--16.44K
--16.44K
----
----
--0
----
----
----
----
----
Other revenue
-74.22%1.11M
-8.24%746.59K
-11.82%299.03K
-10.99%5.9M
-50.81%4.3M
-41.62%813.6K
--339.13K
244.54%6.63M
--8.74M
9.26%1.39M
Operating profit
-4.80%81.47M
-5.60%57.1M
12.71%32.13M
12.18%119.01M
12.28%85.57M
57.11%60.48M
28.5M
21.68%106.08M
76.22M
-11.46%38.5M
Add:Non operating Income
463.05%2.64M
683.21%2.51M
703.93%291.7K
-85.05%757.59K
-78.62%468.57K
-85.37%320.63K
--36.28K
-31.14%5.07M
--2.19M
-0.53%2.19M
Less:Non operating expense
-50.92%49.13K
-50.88%49.12K
-56.58%43.42K
1,934.61%118.85K
1,613.74%100.11K
4,208.97%100K
--100K
-97.28%5.84K
--5.84K
-77.02%2.32K
Total profit
-2.20%84.06M
-1.88%59.56M
13.84%32.38M
7.65%119.64M
9.62%85.94M
49.20%60.7M
108.56%28.44M
17.83%111.15M
78.4M
-10.92%40.69M
Less:Income tax cost
-27.50%6.26M
-34.24%4.52M
-22.15%2.69M
-6.93%11.55M
-8.90%8.63M
41.59%6.88M
--3.45M
-0.35%12.41M
--9.48M
-20.14%4.86M
Net profit
0.63%77.8M
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
104.95%24.99M
20.60%98.73M
68.93M
-9.50%35.83M
Net profit from continuing operation
0.63%77.8M
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
Net profit of parent company owners
0.63%77.8M
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
Earning per share
Basic earning per share
-24.52%1.17
-23.15%0.83
-10.00%0.45
1.52%2
12.44%1.55
50.00%1.08
--0.5
20.12%1.97
--1.3785
-8.86%0.72
Diluted earning per share
-24.52%1.17
-23.15%0.83
-10.00%0.45
1.52%2
12.44%1.55
--1.08
--0.5
--1.97
--1.3785
----
Other composite income
0
Other composite income of parent company owners
----
----
----
----
----
----
----
----
--0
----
Total composite income
0.63%77.8M
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
24.99M
20.60%98.73M
68.93M
-9.50%35.83M
Total composite income of parent company owners
0.63%77.8M
2.25%55.03M
18.81%29.69M
9.48%108.09M
12.17%77.31M
50.23%53.82M
--24.99M
20.60%98.73M
--68.93M
-9.50%35.83M
Total composite income of minority owners
----
----
----
----
----
----
----
----
--0
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 21.88%293.3M13.47%187.21M25.14%90.17M31.07%341.81M33.43%240.65M53.28%164.99M73.61%72.06M23.54%260.78M180.36M7.38%107.64M
Operating revenue 21.88%293.3M13.47%187.21M25.14%90.17M31.07%341.81M33.43%240.65M53.28%164.99M73.61%72.06M23.54%260.78M--180.36M7.38%107.64M
Other operating revenue -----61.52%5.29M----69.20%24.65M----141.61%13.75M----36.76%14.57M----8.45%5.69M
Total operating cost 45.14%231.53M35.63%141.9M47.65%65.35M42.30%230.81M40.09%159.53M46.97%104.63M44.26M28.79%162.2M113.87M23.86%71.19M
Operating cost 42.37%166.75M26.61%100.89M40.59%47.83M34.89%174.53M32.12%117.13M46.29%79.69M--34.02M29.63%129.39M--88.65M20.45%54.47M
Operating tax surcharges 50.13%1.16M87.11%755.01K132.41%369.06K52.93%1.16M27.36%769.57K23.29%403.5K--158.8K-7.72%759.01K--604.26K-15.44%327.27K
Operating expense 13.80%4.31M-28.88%2.21M-28.89%939.77K2.12%4.54M8.23%3.79M37.10%3.11M--1.32M11.55%4.44M--3.5M29.39%2.27M
Administration expense 32.60%18.95M46.23%13.03M75.62%6.81M65.09%20.67M48.91%14.29M40.40%8.91M--3.88M10.01%12.52M--9.6M13.77%6.35M
Financial expense -689.42%-2.68M-1,106.81%-2.14M-3,088.43%-1.33M-418.92%-4.61M34.18%-339.57K46.81%-177.51K---41.81K-114.51%-889.3K---515.89K1.02%-333.73K
-Interest expense (Financial expense) --0------0-97.01%115.79-96.60%115.79-95.56%115.79--115.79-29.40%3.87K--3.41K--2.61K
-Interest Income (Financial expense) -671.10%-2.7M-1,059.65%-2.16M-2,634.98%-1.34M-411.08%-4.63M33.68%-350.41K45.70%-186.28K---48.95K-109.43%-906.05K---528.34K-0.39%-343.03K
Research and development 80.17%43.05M113.95%27.15M118.06%10.74M116.21%34.52M98.48%23.89M56.51%12.69M--4.92M54.31%15.97M--12.04M66.52%8.11M
Credit Impairment Loss -110.47%-2.41M37.38%-920.6K22.10%-104K-81.57%-2.65M-90.85%-1.15M-274.10%-1.47M---133.5K-74.86%-1.46M---600.15K34.86%-393.01K
Asset Impairment Loss -8.73%-1.71M-42.33%-1.38M-43.08%-448.9K-72.38%-1.45M-87.25%-1.57M-84.77%-966.12K---313.73K7.45%-843.55K---838.91K16.84%-522.88K
Other net revenue 342.81%19.69M10,300.71%11.78M936.28%7.3M6.84%8.01M-54.28%4.45M-94.46%113.26K704.92K269.34%7.5M9.73M187.72%2.05M
Fair value change income 2,305.71%20.65M--11.98M--6.88M--3.79M--858.25K--------------0----
Invest income 1.55%2.04M-23.43%1.33M-16.45%679.3K-23.38%2.43M-17.32%2.01M10.72%1.74M--813.02K71.31%3.18M--2.43M134.91%1.57M
Asset deal income --16.44K--16.44K----------0--------------------
Other revenue -74.22%1.11M-8.24%746.59K-11.82%299.03K-10.99%5.9M-50.81%4.3M-41.62%813.6K--339.13K244.54%6.63M--8.74M9.26%1.39M
Operating profit -4.80%81.47M-5.60%57.1M12.71%32.13M12.18%119.01M12.28%85.57M57.11%60.48M28.5M21.68%106.08M76.22M-11.46%38.5M
Add:Non operating Income 463.05%2.64M683.21%2.51M703.93%291.7K-85.05%757.59K-78.62%468.57K-85.37%320.63K--36.28K-31.14%5.07M--2.19M-0.53%2.19M
Less:Non operating expense -50.92%49.13K-50.88%49.12K-56.58%43.42K1,934.61%118.85K1,613.74%100.11K4,208.97%100K--100K-97.28%5.84K--5.84K-77.02%2.32K
Total profit -2.20%84.06M-1.88%59.56M13.84%32.38M7.65%119.64M9.62%85.94M49.20%60.7M108.56%28.44M17.83%111.15M78.4M-10.92%40.69M
Less:Income tax cost -27.50%6.26M-34.24%4.52M-22.15%2.69M-6.93%11.55M-8.90%8.63M41.59%6.88M--3.45M-0.35%12.41M--9.48M-20.14%4.86M
Net profit 0.63%77.8M2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M104.95%24.99M20.60%98.73M68.93M-9.50%35.83M
Net profit from continuing operation 0.63%77.8M2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M
Net profit of parent company owners 0.63%77.8M2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M
Earning per share
Basic earning per share -24.52%1.17-23.15%0.83-10.00%0.451.52%212.44%1.5550.00%1.08--0.520.12%1.97--1.3785-8.86%0.72
Diluted earning per share -24.52%1.17-23.15%0.83-10.00%0.451.52%212.44%1.55--1.08--0.5--1.97--1.3785----
Other composite income 0
Other composite income of parent company owners ----------------------------------0----
Total composite income 0.63%77.8M2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M24.99M20.60%98.73M68.93M-9.50%35.83M
Total composite income of parent company owners 0.63%77.8M2.25%55.03M18.81%29.69M9.48%108.09M12.17%77.31M50.23%53.82M--24.99M20.60%98.73M--68.93M-9.50%35.83M
Total composite income of minority owners ----------------------------------0----
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data